跳至主要内容
临床试验/NCT01668342
NCT01668342已完成1 期

Mobile Phone Text Message Program to Understand Symptoms and Improve Outcomes in Minor Head Injury Patients

University of Pittsburgh2 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2012年6月最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
45
试验地点
2
主要终点
Rivermead Post Concussive Questionnaire

研究概览

简要总结

Mild traumatic brain injury (MTBI) is frequently seen in the ED, post-concussive symptoms are common post-injury, and few MTBI patients receive treatment or follow-up for these symptoms. Cell phones are ubiquitous, text messaging (SMS) is a cheap and increasingly common form of communication, potentially allowing for accurate assessment of symptom patterns after MTBI and provision of basic education support . The investigators seek to assess the feasibility of using SMS to collect symptoms related to MTBI in patients either discharged from the ED or admitted to the inpatient trauma unit. The investigators also seek to explore how SMS-based symptom reports correlate with phone-based follow-up reports at 14 days and whether additional SMS-based educational feedback alters daily symptom patterns.

详细描述

The investigators seek to assess the feasibility of using SMS to collect symptoms related to MTBI in patients either discharged from the ED or admitted to the inpatient trauma unit. The investigators also seek to explore how SMS-based symptom reports correlate with phone-based follow-up reports at 14 days and whether additional SMS-based educational feedback alters daily symptom patterns at 3-months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of minor traumatic brain injury
  • English speaking
  • Owns a cell phone with SMS

排除标准

  • Critically ill

结局指标

主要结局

Rivermead Post Concussive Questionnaire

时间窗: 14 days

次要结局

  • Rivermead Post Concussive Questionnaire(3 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Mobile Phone Text Message Program to Understand... | 临床试验